These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32376522)

  • 1. Successful Infusion of Obinutuzumab by Desensitization: A Case of Anaphylactic Shock During Desensitization.
    Kim KW; Chung S; Lee SY; Yoon SS; Kang HR
    J Investig Allergol Clin Immunol; 2020; 30(6):457-459. PubMed ID: 32376522
    [No Abstract]   [Full Text] [Related]  

  • 2. Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma.
    Gonzalez-Diaz SN; Villarreal-Gonzalez RV; De Lira-Quezada CE; Rocha-Silva GK; Oyervides-Juarez VM; Vidal-Gutierrez O
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):265-267. PubMed ID: 32856592
    [No Abstract]   [Full Text] [Related]  

  • 3. Protocol for Desensitization to Trastuzumab in a Patient With Anaphylaxis and Stage IV Breast Cancer: A Case Report.
    de Lira-Quezada CE; Villarreal-González RV; González-Díaz SN; Acuña-Ortega N
    J Investig Allergol Clin Immunol; 2020; 30(5):376-377. PubMed ID: 32376514
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization.
    Hutten EM; Roeloffzen WW; Lambeck AJ; van den Born-Bondt T; Oude Elberink HN; van de Ven AAJ
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):214-216. PubMed ID: 38888584
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor-monoclonal antibodies and desensitization.
    Labella M; Castells M
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):623-629. PubMed ID: 33781937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
    González-de-Olano D; Morgado JM; Juárez-Guerrero R; Sánchez-Muñoz L; Letellez-Fernández J; Malón-Giménez D; Castells MC
    J Allergy Clin Immunol Pract; 2016; 4(2):338-40. PubMed ID: 26725157
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful desensitization of a patient with Fabry disease with agalsidase beta (Fabrazyme) anaphylaxis after omalizumab pretreatment.
    DuBuske I; Schmidlin K; Bernstein JA
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):96-98. PubMed ID: 32866621
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful rapid tocilizumab desensitization in a patient with Still disease.
    Justet A; Neukirch C; Poubeau P; Arrault X; Borie R; Dombret MC; Crestani B
    J Allergy Clin Immunol Pract; 2014; 2(5):631-2. PubMed ID: 25213064
    [No Abstract]   [Full Text] [Related]  

  • 9. Eculizumab hypersensitivity and desensitization in a toddler with atypical hemolytic uremic syndrome.
    Lo R; Alexander S; Moss J; Siddiqi A; Liu A
    J Allergy Clin Immunol Pract; 2019; 7(7):2409-2410. PubMed ID: 30946976
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective desensitization to imiglucerase in a patient with type I Gaucher disease.
    Peroni DG; Pescollderungg L; Piacentini GL; Cassar W; Boner AL
    J Pediatr; 2009 Dec; 155(6):940-1. PubMed ID: 19914435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab desensitization in three patients with severe rituximab allergy.
    Öztürk E; Özyiğit LP; Öztürk AB; Akay MO; Çetiner M; Ferhanoğlu B
    Curr Probl Cancer; 2017; 41(5):349-354. PubMed ID: 28860080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 13. Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience.
    Autore F; Fresa A; Innocenti I; Tomasso A; Morelli F; Corbingi A; Sorà F; Laurenti L
    Hematol Oncol; 2019 Dec; 37(5):641-643. PubMed ID: 31604368
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid desensitization to doxycycline.
    Fernando SL; Hudson BJ
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):73-4. PubMed ID: 23806469
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylaxis to chemotherapy and monoclonal antibodies.
    Castells MC
    Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Who, What, Where, When, Why, and How of Drug Desensitization.
    Yang BC; Castells MC
    Immunol Allergy Clin North Am; 2022 May; 42(2):403-420. PubMed ID: 35469626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic Shock due to Isatuximab and Successful Desensitization.
    Torres Górriz MC; Borrás Cuartero J; Germán Sánchez A; Pesántez Méndez CG; Stein Coronado CI; Fernández-Delgado M; Beltrán Agost S; Enrique E
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):200-202. PubMed ID: 37812194
    [No Abstract]   [Full Text] [Related]  

  • 18. Inclusion of omalizumab in a trastuzumab desensitization protocol.
    Barreiro-Fernández EM; Gil-Sierra MD; Briceño-Casado MDP; Martínez-Díaz C; Ríos-Sánchez E
    Farm Hosp; 2022 Mar; 46(3):199-201. PubMed ID: 36183214
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment with pembrolizumab after hypersensitivity reaction to nivolumab in a patient with hepatocellular carcinoma.
    Choi B; McBride A; Scott AJ
    Am J Health Syst Pharm; 2019 Oct; 76(21):1749-1752. PubMed ID: 31612928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laronidase desensitization during stem cell transplant in a child with Hurler syndrome.
    Rosenberg J; Jhaveri P; Kelbel T
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):377-8. PubMed ID: 26916445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.